AstraZeneca
-
AstraZeneca’s Beyfortus faces soaring demand amidst RSV surge in U.S.
UNITED KINGDOM — AstraZeneca has announced a strategic focus on meeting the surging demand for its respiratory syncytial virus (RSV) drug, Beyfortus, in the United…
-
AstraZeneca secures exclusive license for promising oral GLP-1 receptor agonist in bid for weight-loss market
UNITED KINGDOM — AstraZeneca has inked an exclusive license agreement with Shanghai-based biotech Eccogene for ECC5004—an early-stage investigational oral glucagon-like peptide 1 receptor agonist (GLP-1RA)…
-
AstraZeneca boosts prostate cancer diagnosis in Kenya with Ultrasound Biopsy Machine donation
KENYA—AstraZeneca has announced the donation of a cutting-edge ultrasound biopsy machine to Kenyatta National Hospital, which will significantly improve prostate cancer diagnosis in Kenya. AstraZeneca…
-
AstraZeneca inaugurates its new sustainable offices in Dubai ahead of COP28
UAE – AstraZeneca has officially launched its new sustainable offices at the TECOM Group’s Dubai Science Park as part of the biopharmaceutical company’s flagship sustainability…
-
Futurize and AstraZeneca launch pioneering HealthTech incubator “FuturizeU” in Africa
AFRICA — Futurize, in partnership with pharmaceutical giant AstraZeneca and co-funded by Bristol Myers Squibb, has officially introduced “FuturizeU,” a groundbreaking HealthTech incubator program set…
-
AstraZeneca and Verge forge AI partnership targeting rare neurological disorders
UNITED KINGDOM — AstraZeneca’s subsidiary, Alexion, has partnered with Verge Genomics, tapping into the power of artificial intelligence (AI) to revolutionize drug discovery for rare…
-
AstraZeneca’s battle against drug price caps pits lifesaving breakthroughs against cost control measures
USA —In a dramatic legal move, pharmaceutical giant AstraZeneca has thrown down the gauntlet against the Biden administration’s attempt to rein in drug prices. The…
-
AstraZeneca’s eco-friendly initiative gains momentum with renewables focus in Sweden
SWEDEN — AstraZeneca, a trailblazer in championing sustainability within the pharmaceutical realm, is intensifying its dedication to clean energy initiatives, particularly in Sweden. The British…
-
CDC backs AstraZeneca and Sanofi’s Beyfortus for infants’ RSV prevention
USA— The U.S. Centers for Disease Control and Prevention (CDC) advisory panel has announced its endorsement of the utilization of Sanofi in collaboration with AstraZeneca’s…
-
Former Alexion head Sharon Barr takes up new EVP role at AstraZeneca
UNITED KINGDOM – AstraZeneca has tapped Sharon Barr as the new Executive Vice President of Biopharmaceuticals Research and Development (R&D) at the Anglo-Swedish pharmaceutical company.…